Eyebiotech Ltd.
Clinical trials sponsored by Eyebiotech Ltd., explained in plain language.
-
New eye drug aims to fight diabetic vision loss
Disease control OngoingThis study is testing a new eye injection called EYE103 to see if it works as well or better than an existing drug (ranibizumab) for diabetic macular edema, a swelling in the back of the eye that causes vision loss in people with diabetes. About 960 participants will receive inje…
Phase: PHASE2, PHASE3 • Sponsor: EyeBiotech Ltd. • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New eye injection trial aims to halt vision loss in common eye diseases
Disease control OngoingThis early-stage study is testing a new drug called EYE201, given as three injections into the eye, to see if it's safe and might help control vision loss. It's for adults with vision problems from diabetic macular edema, age-related macular degeneration, or a retinal vein blocka…
Phase: PHASE1, PHASE2 • Sponsor: EyeBiotech Ltd. • Aim: Disease control
Last updated Mar 23, 2026 15:20 UTC